Epilepsia is the leading, most authoritative source for current clinical and research results on all aspects of epilepsy. As the journal of the International League Against Epilepsy, subscribers every month will review scientific evidence and clinical methodology in: clinical neurology, neurophysiology, molecular biology, neuroimaging, neurochemistry, neurosurgery, pharmacology, neuroepidemiology, and therapeutic trials. In each issue subscribers will find original peer reviewed articles, brief communications, editorial commentaries, meeting reports, and announcements.
| YEAR | Impact Factor |
|---|---|
| 2024-25 | 6.6 |
| 2023 | 6.6 |
| 2022 | 5.6 |
| 2021 | 6.74 |
EPILEPSIA, 0013-9580, WILEY, Medicine,Neuroscience.